DocSym
β
Searchsearch
Search
(Z36.5) Antenatal screening for isoimmunization
More details coming soon
502 917 in individuals diagnosis antenatal screening for isoimmunization confirmed
Diagnosis antenatal screening for isoimmunization is diagnosed Women are 99.73% more likely than Men
668
Men receive the diagnosis antenatal screening for isoimmunization
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
502 249
Women receive the diagnosis antenatal screening for isoimmunization
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease antenatal screening for isoimmunization - Men aged 20-24 and Women aged 35-39
In Men diagnosis is most often set at age 20-24
Less common in men the disease occurs at Age 0-19, 25-95+Less common in women the disease occurs at Age 0-9, 50-95+
In Women diagnosis is most often set at age 0-1, 10-49
Disease Features antenatal screening for isoimmunization
Absence or low individual and public risk
Antenatal screening for isoimmunization - what does this mean
Antenatal screening for isoimmunization is a process used to detect the presence of antibodies in the mother's blood that could potentially cross the placenta and cause a reaction in the fetus. this is done by testing the mother's blood for the presence of rh and other antibodies that could cause an immune reaction in the fetus. if the mother has antibodies present, the fetus may be at risk for developing a range of medical conditions, including anemia, jaundice, and hydrops fetalis.
What happens during the disease - antenatal screening for isoimmunization
Isoimmunization is a condition that occurs when a pregnant woman's body produces antibodies that target and attack the red blood cells of her unborn baby. it is caused by a process known as rh incompatibility, which occurs when the mother has rh-negative blood and the baby has rh-positive blood. the antibodies created by the mother's body can cross the placenta and attack the baby's red blood cells, leading to anemia, jaundice, and other serious health problems. antenatal screening for isoimmunization is used to detect the presence of these antibodies in the mother's blood, allowing for timely interventions to reduce the risk of complications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete Blood Count (CBC)
- Rhesus (Rh) typing
- Antibody screening
- Ultrasound to assess the baby's anatomy
- Amniocentesis
- Fetal blood sampling
- Fetal echocardiogram
- Placental biopsy
Treatment and Medical Assistance
Main Goal: To prevent Rh isoimmunization in pregnant women
- Monitoring of Rh status of pregnant women
- Administering Rh immune globulin to Rh-negative pregnant women
- Monitoring of fetal Rh status
- Administering Rh immune globulin to Rh-positive fetuses
- Administering anti-D immunoglobulin to Rh-positive fetuses
- Monitoring of maternal and fetal antibody levels
- Providing education to pregnant women about Rh isoimmunization
- Providing counseling to pregnant women about Rh isoimmunization
Less than a Day of Hospitalization Required
58 Hours Required for Outpatient Treatment
Antenatal screening for isoimmunization - Prevention
Antenatal screening for isoimmunization is a preventative measure to identify and monitor pregnant women who are at risk for developing antibodies against their baby's red blood cells. this is done by testing the mother's blood for the presence of specific antibodies that can cause an immune response. early detection and treatment can help prevent serious complications for the baby.